Shin Hisahara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shin Hisahara has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
Kazuki Yokokawa
Department of Neurology, School of Medicine Sapporo Medical University Sapporo Hokkaido Japan
10 shared publicationsSyuuichirou Suzuki
Department of Neurology, School of Medicine Sapporo Medical University Sapporo Hokkaido Japan
10 shared publicationsKazuna Ikeda
Department of Neurology, School of Medicine Sapporo Medical University Sapporo Hokkaido Japan
7 shared publicationsShun Shimohama
Department of Neurology, Sapporo Medical University, School of Medicine, Japan
7 shared publications- Shun Shimohama
Department of Neurology, School of Medicine, Sapporo Medical University, Sapporo 060-8543, Japan
7 shared publications Akihiro Matsumura
Department of Neurology, Sapporo Medical University School of Medicine, Japan
6 shared publications
Latest Publications
- 26 October 2026
- Published by Wiley in Neurology and Clinical Neuroscience
Marked Peripheral Blood Plasmablast Expansion in MOG Antibody‐Associated Disease and Anti‐ NMDA Receptor Encephalitis Overlap Syndrome
Following upper respiratory symptoms, a 30‐year‐old man developed right eye pain, psychiatric symptoms, cognitive decline, and status epilepticus. Brain MRI showed unilateral cortical FLAIR hyperintensity consistent with FLAMES (FLAIR‐hyperintense lesions in anti‐MOG‐associated encephalitis with seizures). Serum anti‐MOG antibodies and cerebrospinal fluid (CSF) anti‐NMDAR antibodies established MOG antibody‐associated disease (MOGAD) and anti‐NMDAR encephalitis overlapping syndrome (MNOS). Flow cytometry revealed marked expansion of peripheral blood plasmablasts (IgD − CD19 + CD20 − CD24 − CD27 + CD38 + CD138 − ), comprising 13.6% of peripheral blood B cells, whereas CSF B cells were predominantly naïve B cells with virtually no detectable plasmablasts and plasma cells. Following immunotherapy, peripheral blood plasmablasts decreased to 2.0% in parallel with clinical recovery, while CSF B cells shifted toward memory predominance. This case demonstrates a dissociation between peripheral blood plasmablast expansion and absent intrathecal plasmablast accumulation in MNOS, suggesting that peripheral blood B‐cell profiling may warrant further evaluation in MNOS.
- 26 October 2026
- Published by Wiley in Neurology and Clinical Neuroscience
Marked Peripheral Blood Plasmablast Expansion in MOG Antibody‐Associated Disease and Anti‐ NMDA Receptor Encephalitis Overlap Syndrome
Following upper respiratory symptoms, a 30‐year‐old man developed right eye pain, psychiatric symptoms, cognitive decline, and status epilepticus. Brain MRI showed unilateral cortical FLAIR hyperintensity consistent with FLAMES (FLAIR‐hyperintense lesions in anti‐MOG‐associated encephalitis with seizures). Serum anti‐MOG antibodies and cerebrospinal fluid (CSF) anti‐NMDAR antibodies established MOG antibody‐associated disease (MOGAD) and anti‐NMDAR encephalitis overlapping syndrome (MNOS). Flow cytometry revealed marked expansion of peripheral blood plasmablasts (IgD − CD19 + CD20 − CD24 − CD27 + CD38 + CD138 − ), comprising 13.6% of peripheral blood B cells, whereas CSF B cells were predominantly naïve B cells with virtually no detectable plasmablasts and plasma cells. Following immunotherapy, peripheral blood plasmablasts decreased to 2.0% in parallel with clinical recovery, while CSF B cells shifted toward memory predominance. This case demonstrates a dissociation between peripheral blood plasmablast expansion and absent intrathecal plasmablast accumulation in MNOS, suggesting that peripheral blood B‐cell profiling may warrant further evaluation in MNOS.
- 28 April 2026
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 14 (4) , 303-306
Autoimmune Epilepsy With Isolated Serum Positivity for Anti–Gamma‐Aminobutyric Acid Type A Receptor Antibodies: A Case Report
A 67‐year‐old woman has experienced recurrent generalized seizures since 2022 and was admitted to our department on multiple occasions. No neurological deficits or cerebrospinal fluid (CSF) abnormalities were observed during the interictal periods. Brain MRI revealed multifocal, reversible cortical–subcortical FLAIR hyperintense lesions. Antiepileptic drugs were administered, and the patient has remained seizure‐free. Epilepsy due to an immune‐mediated mechanism was suspected. Anti‐gamma‐aminobutyric acid type A (GABA A ) receptor antibodies were identified in the serum but not in the CSF using a cell‐based assay. Although GABA A receptor antibodies are typically detectable in both serum and CSF, several reports have described cases with serum‐only positivity. Our case highlights that autoimmune epilepsy may present without overt encephalitic features and with isolated serum antibody positivity. Therefore, negative CSF results do not necessarily exclude antibody‐mediated disease, and concurrent testing of both serum and CSF is recommended in clinical practice.
- 28 April 2026
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 14 (4) , 303-306
Autoimmune Epilepsy With Isolated Serum Positivity for Anti–Gamma‐Aminobutyric Acid Type A Receptor Antibodies: A Case Report
A 67‐year‐old woman has experienced recurrent generalized seizures since 2022 and was admitted to our department on multiple occasions. No neurological deficits or cerebrospinal fluid (CSF) abnormalities were observed during the interictal periods. Brain MRI revealed multifocal, reversible cortical–subcortical FLAIR hyperintense lesions. Antiepileptic drugs were administered, and the patient has remained seizure‐free. Epilepsy due to an immune‐mediated mechanism was suspected. Anti‐gamma‐aminobutyric acid type A (GABA A ) receptor antibodies were identified in the serum but not in the CSF using a cell‐based assay. Although GABA A receptor antibodies are typically detectable in both serum and CSF, several reports have described cases with serum‐only positivity. Our case highlights that autoimmune epilepsy may present without overt encephalitic features and with isolated serum antibody positivity. Therefore, negative CSF results do not necessarily exclude antibody‐mediated disease, and concurrent testing of both serum and CSF is recommended in clinical practice.
- Open Access
- 15 December 2025
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 64 (24) , 3586
Response to SARS-CoV-2 Infection in Sjögren Syndrome Can Be Complicated by Myelitis and Guillain-Barré Syndrome
- 15 December 2025
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 64 (24) , 3586
Open AccessResponse to SARS-CoV-2 Infection in Sjögren Syndrome Can Be Complicated by Myelitis and Guillain-Barré Syndrome
- Open Access
- 15 October 2025
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 64 (20) , 3033-3038
Sjögren's Syndrome with Sensory Neuronopathy and Polyradiculoneuropathy
41-year-old female became difficulty walking due to sensory ataxia in the limbs and trunk. A diagnosis of Sjögren's syndrome was made on the results of positive anti-SS-A antibody and a lip gland biopsy. Nerve conduction studies indicated sensory neuronopathy. The symptoms improved following treatment with plasma exchange, intravenous immunoglobulin, and intravenous methylprednisolone. Nine months later, the patient's sensory ataxia worsened. Nerve conduction studies revealed the coexistence of sensory neuronopathy and polyradiculoneuropathy. The symptoms improved following treatment with intravenous cyclophosphamide and intravenous immunoglobulin. This case represents the first instance of sensory neuronopathy and polyradiculoneuropathy coexisting as Sjögren's syndrome related neuropathy.
- 15 October 2025
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 64 (20) , 3033-3038
Open AccessSjögren's Syndrome with Sensory Neuronopathy and Polyradiculoneuropathy
41-year-old female became difficulty walking due to sensory ataxia in the limbs and trunk. A diagnosis of Sjögren's syndrome was made on the results of positive anti-SS-A antibody and a lip gland biopsy. Nerve conduction studies indicated sensory neuronopathy. The symptoms improved following treatment with plasma exchange, intravenous immunoglobulin, and intravenous methylprednisolone. Nine months later, the patient's sensory ataxia worsened. Nerve conduction studies revealed the coexistence of sensory neuronopathy and polyradiculoneuropathy. The symptoms improved following treatment with intravenous cyclophosphamide and intravenous immunoglobulin. This case represents the first instance of sensory neuronopathy and polyradiculoneuropathy coexisting as Sjögren's syndrome related neuropathy.
- Open Access
- 1 September 2025
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 12 (5) , e200442
Elevated ITGAX/CD11c in CSF-Derived Extracellular Vesicles Reflects Disability Progression in Multiple Sclerosis
Extracellular vesicles (EVs) are membrane-bound particles that are released into the extracellular space and are believed to play a role in the pathogenesis of neuroinflammation and neurodegeneration. Nevertheless, the precise role of these vesicles in the context of multiple sclerosis (MS) remains uncertain. The objective of this study was to identify the distinctive characteristics of EVs associated with MS. EVs were isolated from CSF using phosphatidylserine affinity methods. Mass spectrometry was used to analyze CSF samples and EVs isolated from those CSF samples collected from a discovery cohort of 10 patients with other neurologic diseases (ONDs) and 10 patients with MS. In addition, mass spectrometry was used to analyze EVs isolated from CSF samples in a validation cohort of 24 patients with ONDs, 38 patients with MS, and 14 patients with neuromyelitis optica spectrum disorders. The results revealed notable increases in the levels of 33 proteins in the CSF samples and 100 proteins in the CSF-derived EVs from patients with MS in the validation cohort. Increases in the levels of ITGA4, ITGAX (CD11c), MS4A1 (CD20), CD3E, CD4, and CD8A, which are marker proteins of lymphocytes and myeloid cells, including activated microglia and dendritic cells, were observed in the CSF-derived EVs in the discovery cohort. The results of the validation cohort revealed that the levels of 4 proteins, ITGA4, ITGAX, MS4A1, and CD3E, were significantly greater in patients with MS than in patients with ONDs. Furthermore, the level of ITGAX was greater in the patients with confirmed disability worsening (CDW) than in those without CDW. The results of the receiver operating characteristic (ROC) and Kaplan-Meier analyses indicated that ITGAX levels in CSF-derived EVs may prove useful in predicting disease prognosis. Our findings suggest that CSF-derived EVs reflect immunologic changes in MS and other neuroimmune diseases. In addition, these results raise the possibility that changing in myeloid cells and lymphocytes may also play a role in the pathogenesis of MS. CSF-derived EVs may serve as indicators of MS disease severity and could be used as biomarkers in the future.
- 1 September 2025
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 12 (5) , e200442
Open AccessElevated ITGAX/CD11c in CSF-Derived Extracellular Vesicles Reflects Disability Progression in Multiple Sclerosis
Extracellular vesicles (EVs) are membrane-bound particles that are released into the extracellular space and are believed to play a role in the pathogenesis of neuroinflammation and neurodegeneration. Nevertheless, the precise role of these vesicles in the context of multiple sclerosis (MS) remains uncertain. The objective of this study was to identify the distinctive characteristics of EVs associated with MS. EVs were isolated from CSF using phosphatidylserine affinity methods. Mass spectrometry was used to analyze CSF samples and EVs isolated from those CSF samples collected from a discovery cohort of 10 patients with other neurologic diseases (ONDs) and 10 patients with MS. In addition, mass spectrometry was used to analyze EVs isolated from CSF samples in a validation cohort of 24 patients with ONDs, 38 patients with MS, and 14 patients with neuromyelitis optica spectrum disorders. The results revealed notable increases in the levels of 33 proteins in the CSF samples and 100 proteins in the CSF-derived EVs from patients with MS in the validation cohort. Increases in the levels of ITGA4, ITGAX (CD11c), MS4A1 (CD20), CD3E, CD4, and CD8A, which are marker proteins of lymphocytes and myeloid cells, including activated microglia and dendritic cells, were observed in the CSF-derived EVs in the discovery cohort. The results of the validation cohort revealed that the levels of 4 proteins, ITGA4, ITGAX, MS4A1, and CD3E, were significantly greater in patients with MS than in patients with ONDs. Furthermore, the level of ITGAX was greater in the patients with confirmed disability worsening (CDW) than in those without CDW. The results of the receiver operating characteristic (ROC) and Kaplan-Meier analyses indicated that ITGAX levels in CSF-derived EVs may prove useful in predicting disease prognosis. Our findings suggest that CSF-derived EVs reflect immunologic changes in MS and other neuroimmune diseases. In addition, these results raise the possibility that changing in myeloid cells and lymphocytes may also play a role in the pathogenesis of MS. CSF-derived EVs may serve as indicators of MS disease severity and could be used as biomarkers in the future.
- Open Access
- 20 January 2025
- Published by Springer Nature in Cureus
- Vol. 17 (1) , e77700
A Case of Multiple Intracerebral Hemorrhages Due to Early-Onset Cerebral Amyloid Angiopathy With Alzheimer’s Disease: Neuropathological Changes Three Decades After Childhood Neurosurgery
Cerebral amyloid angiopathy (CAA) is a disease in which amyloid beta (Aβ) is deposited in blood vessels and meninges in the brain. Cerebral amyloid angiopathy typically occurs in the elderly but is also known to occur in younger patients with a history of childhood head trauma or dura graft following neurosurgical procedures.
- 20 January 2025
- Published by Springer Nature in Cureus
- Vol. 17 (1) , e77700
Open AccessA Case of Multiple Intracerebral Hemorrhages Due to Early-Onset Cerebral Amyloid Angiopathy With Alzheimer’s Disease: Neuropathological Changes Three Decades After Childhood Neurosurgery
Cerebral amyloid angiopathy (CAA) is a disease in which amyloid beta (Aβ) is deposited in blood vessels and meninges in the brain. Cerebral amyloid angiopathy typically occurs in the elderly but is also known to occur in younger patients with a history of childhood head trauma or dura graft following neurosurgical procedures.
- Open Access
- 1 August 2023
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 62 (15) , 2261-2266
Transthyretin Variant Amyloidosis with a TTR A97D (p.A117D) Mutation Manifesting Remarkable Asymmetric Neuropathy
We herein report a 68-year-old Japanese man with sporadic variant transthyretin (ATTRv) amyloidosis harboring the novel variant A97D (p.A117D) in TTR. He had slow development of asymmetric neuropathy, unintentional weight loss, mild autonomic failure and mild cardiomyopathy. TTR amyloid deposition on the gastric duodenal mucosa was detected. In silico analyses predicted that TTR A97D (p.A117D) altered the structure and function of the TTR protein. ATTRv amyloidosis is often difficult to diagnose in non-endemic regions due to its diverse phenotypes, such as atypical peripheral nerve involvement and a rare family history.
- 1 August 2023
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 62 (15) , 2261-2266
Open AccessTransthyretin Variant Amyloidosis with a TTR A97D (p.A117D) Mutation Manifesting Remarkable Asymmetric Neuropathy
We herein report a 68-year-old Japanese man with sporadic variant transthyretin (ATTRv) amyloidosis harboring the novel variant A97D (p.A117D) in TTR. He had slow development of asymmetric neuropathy, unintentional weight loss, mild autonomic failure and mild cardiomyopathy. TTR amyloid deposition on the gastric duodenal mucosa was detected. In silico analyses predicted that TTR A97D (p.A117D) altered the structure and function of the TTR protein. ATTRv amyloidosis is often difficult to diagnose in non-endemic regions due to its diverse phenotypes, such as atypical peripheral nerve involvement and a rare family history.
- Open Access
- 1 December 2022
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 61 (23) , 3605-3609
Anti-signal Recognition Particle Antibody-positive Immune-mediated Myopathy after mRNA-1273 SARS-CoV-2 Vaccination
A 26-year-old Japanese woman developed a fever, myalgia and gait disturbance one day after receiving the second dose of the mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. A neurological examination revealed symmetrical weakness and myalgia in proximal lower limbs, and a blood examination showed prominent elevation of creatinine kinase. Magnetic resonance imaging (MRI) revealed a high signal intensity in the thigh muscles on short-tau inversion recovery images, and antibody testing revealed positive findings for anti-signal recognition particle (SRP) antibody. Thus, anti-SRP antibody-positive immune-mediated myopathy was diagnosed. We initiated immunotherapy, and she was ultimately able to walk stably.
- 1 December 2022
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 61 (23) , 3605-3609
Open AccessAnti-signal Recognition Particle Antibody-positive Immune-mediated Myopathy after mRNA-1273 SARS-CoV-2 Vaccination
A 26-year-old Japanese woman developed a fever, myalgia and gait disturbance one day after receiving the second dose of the mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. A neurological examination revealed symmetrical weakness and myalgia in proximal lower limbs, and a blood examination showed prominent elevation of creatinine kinase. Magnetic resonance imaging (MRI) revealed a high signal intensity in the thigh muscles on short-tau inversion recovery images, and antibody testing revealed positive findings for anti-signal recognition particle (SRP) antibody. Thus, anti-SRP antibody-positive immune-mediated myopathy was diagnosed. We initiated immunotherapy, and she was ultimately able to walk stably.
- Open Access
- 2 November 2022
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 62 (12) , 1827-1833
Cerebral Tuberculoma Diagnosed by Nested Polymerase Chain Reaction of a Formalin-fixed Paraffin-embedded Brain Biopsy Sample
A 38-year-old man was taken to hospital with generalized clonic seizure. Brain magnetic resonance imaging (MRI) showed multiple ring-enhancing lesions centered in the left frontoparietal lobe. A histopathological examination of a brain biopsy sample revealed granulomatous lesions with caseous necrosis. We extracted DNA from a formalin-fixed paraffin-embedded (FFPE) brain specimen, and nested polymerase chain reaction (PCR) of the DNA sample detected the Mycobacterium tuberculosis-specific insertion sequence IS6110. The lesions worsened after anti-tuberculosis drugs were administered, which we considered to be a paradoxical response and continued treatment. A genetic diagnosis of M. tuberculosis using FFPE specimens is useful for diagnosing tuberculoma.
- 2 November 2022
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 62 (12) , 1827-1833
Open AccessCerebral Tuberculoma Diagnosed by Nested Polymerase Chain Reaction of a Formalin-fixed Paraffin-embedded Brain Biopsy Sample
A 38-year-old man was taken to hospital with generalized clonic seizure. Brain magnetic resonance imaging (MRI) showed multiple ring-enhancing lesions centered in the left frontoparietal lobe. A histopathological examination of a brain biopsy sample revealed granulomatous lesions with caseous necrosis. We extracted DNA from a formalin-fixed paraffin-embedded (FFPE) brain specimen, and nested polymerase chain reaction (PCR) of the DNA sample detected the Mycobacterium tuberculosis-specific insertion sequence IS6110. The lesions worsened after anti-tuberculosis drugs were administered, which we considered to be a paradoxical response and continued treatment. A genetic diagnosis of M. tuberculosis using FFPE specimens is useful for diagnosing tuberculoma.
- Open Access
- 15 June 2021
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 60 (12) , 1949-1953
Sporadic Amyotrophic Lateral Sclerosis Due to a FUS P525L Mutation with Asymmetric Muscle Weakness and Anti-ganglioside Antibodies
Amyotrophic lateral sclerosis (ALS) due to a fused in sarcoma (FUS) P525L mutation is characterized by a rapidly progressive course. Multifocal motor neuropathy (MMN) may resemble ALS in early stage and is associated with anti-ganglioside antibodies. A 38-year-old woman was admitted to our hospital because of progressive muscle weakness in the right limbs. She had mild mental retardation and minor deformities. Initially, we suspected MMN given the asymmetric muscle weakness and detection of anti-ganglioside antibodies. However, physical and electrophysiological tests did not support MMN, instead suggesting ALS. We confirmed a heterozygous P525L mutation and finally diagnosed this case as ALS due to an FUS mutation.
- 15 June 2021
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 60 (12) , 1949-1953
Open AccessSporadic Amyotrophic Lateral Sclerosis Due to a FUS P525L Mutation with Asymmetric Muscle Weakness and Anti-ganglioside Antibodies
Amyotrophic lateral sclerosis (ALS) due to a fused in sarcoma (FUS) P525L mutation is characterized by a rapidly progressive course. Multifocal motor neuropathy (MMN) may resemble ALS in early stage and is associated with anti-ganglioside antibodies. A 38-year-old woman was admitted to our hospital because of progressive muscle weakness in the right limbs. She had mild mental retardation and minor deformities. Initially, we suspected MMN given the asymmetric muscle weakness and detection of anti-ganglioside antibodies. However, physical and electrophysiological tests did not support MMN, instead suggesting ALS. We confirmed a heterozygous P525L mutation and finally diagnosed this case as ALS due to an FUS mutation.